{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:59:59Z","timestamp":1778227199635,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"general projects of provincial natural science foundation","award":["2019JJ40480"],"award-info":[{"award-number":["2019JJ40480"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although long noncoding RNA HLA complex group 18 (lncRNA HCG18) has been suggested to regulate cell growth in several tumours, the function of HCG18 in epithelial ovarian cancer (EOC) and its mechanism are still unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>shRNAs were applied to reduce HCG18 and related genes. For overexpression of miRNA, a miRNA mimic was transfected into cells. Quantitative real-time PCR (qRT\u2013PCR) was used to detect levels of HCG18, miR-29a\/b, and mRNAs. MTT, colony formation, wound healing and Transwell assays were used to evaluate cell proliferation, migration and invasion, respectively. A luciferase reporter assay was utilized to evaluate NF-\u03baB activity and the binding of miRNAs with HCG18 or TRAF4\/5. BALB nude mice injected with cells stably expressing shHCG18 or shNC were used for in vivo modelling. Subcutaneous tumour growth was monitored in nude mice, and immunohistochemistry (IHC) was used to determine expression of the proliferation marker Ki67.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Abnormal expression of HCG18 and miR-29a\/b was observed in EOC tissues. Knockdown of HCG18 using shRNA inhibited proliferation, migration, EMT and the proinflammatory pathway in EOC cells. miR-29a\/b mimics and TRAF4\/5 knockdown exhibited effects similar to HCG18 knockdown. Further experiments suggested that HCG18 directly targets miR-29a\/b and upregulates TRAF4\/5 expression, which are inhibited by targeting miR-29a\/b. Moreover, overexpression of TRAF4\/5 antagonized the inhibitory effect of HCG18 knockdown, suggesting that they are involved in HCG18-mediated oncogenic effects. Silencing HCG18 reduced tumour size and levels of Ki67 and TRAF4\/5 while increasing miR-29a\/b levels in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Taken together, our data revealed an oncogenic signalling pathway mediated by HCG18 in ovarian cell lines, which functions as a ceRNA of miR-29a\/b and thus derepresses expression levels of TRAF4\/5, facilitating NF-\u03baB pathway-mediated promotion of EOC cell proliferation and migration.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-021-00415-y","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T12:02:54Z","timestamp":1641297774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["LncRNA HCG18 upregulates TRAF4\/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a\/b"],"prefix":"10.1186","volume":"28","author":[{"given":"Fan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai-Hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3706-4254","authenticated-orcid":false,"given":"Ke-Da","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"key":"415_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.trsl.2017.10.012","volume":"195","author":"M Abdullah","year":"2018","unstructured":"Abdullah M, Berthiaume JM, Willis MS. Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all. Transl Res. 2018;195:48\u201361.","journal-title":"Transl Res"},{"key":"415_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/JLB.5RI0917-380RR","volume":"104","author":"GP Andrieu","year":"2018","unstructured":"Andrieu GP, et al. BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment. J Leukoc Biol. 2018;104:265\u201374.","journal-title":"J Leukoc Biol"},{"key":"415_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1479-5876-4-16","volume":"4","author":"SM Apte","year":"2006","unstructured":"Apte SM, et al. Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin. J Transl Med. 2006;4:16.","journal-title":"J Transl Med"},{"key":"415_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","volume":"35","author":"CL Chaffer","year":"2016","unstructured":"Chaffer CL, San Juan BP, Lim E, Weinberg RA. EMT, cell plasticity and metastasis. Cancer Metast Rev. 2016;35:645\u201354.","journal-title":"Cancer Metast Rev"},{"key":"415_CR5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s10067-018-4023-4","volume":"37","author":"Y Chen","year":"2018","unstructured":"Chen Y, et al. Recurrent fever and arthralgia as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Chinese girl: a case report and review of the literature. Clin Rheumatol. 2018;37:1433\u20138.","journal-title":"Clin Rheumatol"},{"key":"415_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2147\/CMAR.S183310","volume":"11","author":"LP Chen","year":"2019","unstructured":"Chen LP, et al. Robust analysis of novel mRNA-lncRNA cross talk based on ceRNA hypothesis uncovers carcinogenic mechanism and promotes diagnostic accuracy in esophageal cancer. Cancer Manag Res. 2019;11:347\u201358.","journal-title":"Cancer Manag Res"},{"key":"415_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbi.2012.04.003","volume":"26","author":"L Clevenger","year":"2012","unstructured":"Clevenger L, et al. Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav Immun. 2012;26:1037\u201344.","journal-title":"Brain Behav Immun"},{"key":"415_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature13062","volume":"507","author":"SB Coffelt","year":"2014","unstructured":"Coffelt SB, de Visser KE. Cancer: Inflammation lights the way to metastasis. Nature. 2014;507:48\u20139.","journal-title":"Nature"},{"key":"415_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature"},{"key":"415_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fonc.2012.00033","volume":"2","author":"B Davidson","year":"2012","unstructured":"Davidson B, Trope CG, Reich R. Epithelial-mesenchymal transition in ovarian carcinoma. Front Oncol. 2012;2:33.","journal-title":"Front Oncol"},{"key":"415_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00428-015-1818-4","volume":"467","author":"E De Vlieghere","year":"2015","unstructured":"De Vlieghere E, Verset L, Demetter P, Bracke M, De Wever O. Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics. Virchows Arch. 2015;467:367\u201382.","journal-title":"Virchows Arch"},{"key":"415_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ceb.2016.06.002","volume":"43","author":"M Diepenbruck","year":"2016","unstructured":"Diepenbruck M, Christofori G. Epithelial\u2013mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol. 2016;43:7\u201313.","journal-title":"Curr Opin Cell Biol"},{"key":"415_CR13","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1007\/s00018-004-4417-0","volume":"61","author":"EM Esparza","year":"2004","unstructured":"Esparza EM, Arch RH. TRAF4 functions as an intermediate of GITR-induced NF-kappa B activation. Cell Mol Life Sci. 2004;61:3087\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"415_CR14","doi-asserted-by":"publisher","first-page":"a028662","DOI":"10.1101\/cshperspect.a028662","volume":"10","author":"MR Galdiero","year":"2018","unstructured":"Galdiero MR, Marone G, Mantovani A. Cancer inflammation and cytokines. Cold Spring Harb Perspect Biol. 2018;10:a028662.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"415_CR15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s10067-017-3688-4","volume":"36","author":"S Gentileschi","year":"2017","unstructured":"Gentileschi S, et al. Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature. Clin Rheumatol. 2017;36:1687\u201390.","journal-title":"Clin Rheumatol"},{"key":"415_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fonc.2016.00108","volume":"6","author":"SH George","year":"2016","unstructured":"George SH, Garcia R, Slomovitz BM. Ovarian cancer: the fallopian tube as the site of origin and opportunities for prevention. Front Oncol. 2016;6:108.","journal-title":"Front Oncol"},{"key":"415_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/1471-2407-14-477","volume":"14","author":"WF Gou","year":"2014","unstructured":"Gou WF, et al. The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells. BMC Cancer. 2014;14:477.","journal-title":"BMC Cancer"},{"key":"415_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/1878-0261.12083","volume":"11","author":"MK Jolly","year":"2017","unstructured":"Jolly MK, Ware KE, Gilja S, Somarelli JA, Levine H. EMT and MET: necessary or permissive for metastasis? Mol Oncol. 2017;11:755\u201369.","journal-title":"Mol Oncol"},{"key":"415_CR19","first-page":"181","volume":"74","author":"BM Kacinski","year":"1995","unstructured":"Kacinski BM. Tumor-stromal cytokine interactions in ovarian neoplasms. EXS. 1995;74:181\u201390.","journal-title":"EXS"},{"key":"415_CR20","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial\u2013mesenchymal transition. J Clin Invest. 2009;119:1420\u20138.","journal-title":"J Clin Invest"},{"key":"415_CR21","doi-asserted-by":"publisher","first-page":"8923","DOI":"10.1038\/s41598-017-09447-z","volume":"7","author":"E Kim","year":"2017","unstructured":"Kim E, et al. TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts. Sci Rep. 2017;7:8923.","journal-title":"Sci Rep"},{"key":"415_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ygyno.2015.05.009","volume":"138","author":"N Kolomeyevskaya","year":"2015","unstructured":"Kolomeyevskaya N, et al. Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-alpha and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer. Gynecol Oncol. 2015;138:352\u20137.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"415_CR23","doi-asserted-by":"publisher","first-page":"9105","DOI":"10.1002\/jcp.27587","volume":"234","author":"X Kong","year":"2018","unstructured":"Kong X, et al. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2018;234(6):9105\u201317.","journal-title":"J Cell Physiol"},{"key":"415_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.canlet.2014.05.022","volume":"351","author":"M Koutsaki","year":"2014","unstructured":"Koutsaki M, Spandidos DA, Zaravinos A. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics. Cancer Lett. 2014;351:173\u201381.","journal-title":"Cancer Lett"},{"key":"415_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1006\/cyto.1998.0504","volume":"12","author":"S Kuninaka","year":"2000","unstructured":"Kuninaka S, et al. Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells. Cytokine. 2000;12:8\u201311.","journal-title":"Cytokine"},{"key":"415_CR26","first-page":"361","volume":"31","author":"QL Li","year":"2000","unstructured":"Li QL, Ni J. Regulatory role of cytokine in the ovarian function. Sheng Li Ke Xue Jin Zhan. 2000;31:361\u20133.","journal-title":"Sheng Li Ke Xue Jin Zhan"},{"key":"415_CR27","first-page":"1529","volume":"41","author":"LW Li","year":"2018","unstructured":"Li LW, et al. miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3. Int J Mol Med. 2018;41:1529\u201335.","journal-title":"Int J Mol Med"},{"key":"415_CR28","first-page":"10387","volume":"23","author":"L Li","year":"2019","unstructured":"Li L, Ma TT, Ma YH, Jiang YF. LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140\/CCND1 and Hedgehog signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23:10387\u201399.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"415_CR29","doi-asserted-by":"publisher","first-page":"110217","DOI":"10.1016\/j.biopha.2020.110217","volume":"129","author":"W Li","year":"2020","unstructured":"Li W, Pan T, Jiang W, Zhao H. HCG18\/miR-34a-5p\/HMMR axis accelerates the progression of lung adenocarcinoma. Biomed Pharmacother. 2020a;129:110217.","journal-title":"Biomed Pharmacother"},{"key":"415_CR30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/1440-1681.13230","volume":"47","author":"S Li","year":"2020","unstructured":"Li S, Wu T, Zhang D, Sun X, Zhang X. The long non-coding RNA HCG18 promotes the growth and invasion of colorectal cancer cells through sponging miR-1271 and upregulating MTDH\/Wnt\/beta-catenin. Clin Exp Pharmacol Physiol. 2020b;47:703\u201312.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"415_CR31","first-page":"1752","volume":"53","author":"Y Liu","year":"2018","unstructured":"Liu Y, Dong Y, Zhao L, Su L, Luo J. Circular RNAMTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4\/Eg5 axis. Int J Oncol. 2018;53:1752\u201362.","journal-title":"Int J Oncol"},{"key":"415_CR32","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1002\/cam4.3288","volume":"9","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. Long noncoding RNA HCG18 up-regulates the expression of WIPF1 and YAP\/TAZ by inhibiting miR-141-3p in gastric cancer. Cancer Med. 2020;9:6752\u201365.","journal-title":"Cancer Med"},{"key":"415_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2015.3234","volume":"48","author":"X Long","year":"2016","unstructured":"Long X, et al. IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review). Int J Oncol. 2016;48:5\u201312.","journal-title":"Int J Oncol"},{"key":"415_CR34","doi-asserted-by":"publisher","first-page":"7641","DOI":"10.2147\/OTT.S253391","volume":"13","author":"P Ma","year":"2020","unstructured":"Ma P, Li L, Liu F, Zhao Q. HNF1A-induced lncRNA HCG18 facilitates gastric cancer progression by upregulating DNAJB12 via miR-152-3p. Onco Targets Ther. 2020;13:7641\u201352.","journal-title":"Onco Targets Ther"},{"key":"415_CR35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344.","journal-title":"Nature"},{"key":"415_CR36","first-page":"566","volume":"2","author":"I Matte","year":"2012","unstructured":"Matte I, Lane D, Laplante C, Rancourt C, Piche A. Profiling of cytokines in human epithelial ovarian cancer ascites. Am J Cancer Res. 2012;2:566\u201380.","journal-title":"Am J Cancer Res"},{"key":"415_CR37","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.2174\/0929867324666170920160030","volume":"25","author":"R Molinaro","year":"2018","unstructured":"Molinaro R, et al. Inflammation and cancer. in medio stat nano. Curr Med Chem. 2018;25:4208\u201323.","journal-title":"Curr Med Chem"},{"key":"415_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2018.1486143","volume":"12","author":"LA Moraes","year":"2018","unstructured":"Moraes LA, Ampomah PB, Lim LHK. Annexin A1 in inflammation and breast cancer: a new axis in the tumor microenvironment. Cell Adh Migr. 2018;12:1\u20137.","journal-title":"Cell Adh Migr"},{"issue":"3","key":"415_CR39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2018;29(3):212\u201326.","journal-title":"Trends Cell Biol"},{"key":"415_CR40","first-page":"1672","volume":"15","author":"W Qin","year":"2018","unstructured":"Qin W, et al. MicroRNA-152 inhibits ovarian cancer cell proliferation and migration and may infer improved outcomes in ovarian cancer through targeting FOXP1. Exp Ther Med. 2018;15:1672\u20139.","journal-title":"Exp Ther Med"},{"issue":"230","key":"415_CR41","first-page":"e231","volume":"203","author":"KS Rath","year":"2010","unstructured":"Rath KS, Funk HM, Bowling MC, Richards WE, Drew AF. Expression of soluble interleukin-6 receptor in malignant ovarian tissue. Am J Obstet Gynecol. 2010;203(230):e231-238.","journal-title":"Am J Obstet Gynecol"},{"key":"415_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11010-020-03923-3","volume":"476","author":"W Ren","year":"2021","unstructured":"Ren W, et al. Long non-coding RNA HCG18 promotes M1 macrophage polarization through regulating the miR-146a\/TRAF6 axis, facilitating the progression of diabetic peripheral neuropathy. Mol Cell Biochem. 2021;476:471\u201382.","journal-title":"Mol Cell Biochem"},{"key":"415_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/onc.2016.197","volume":"36","author":"U Saini","year":"2017","unstructured":"Saini U, et al. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target. Oncogene. 2017;36:168\u201381.","journal-title":"Oncogene"},{"key":"415_CR44","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3389\/fimmu.2018.01849","volume":"9","author":"JH Shi","year":"2018","unstructured":"Shi JH, Sun SC. Tumor necrosis factor receptor-associated factor regulation of nuclear factor kappaB and mitogen-activated protein kinase pathways. Front Immunol. 2018;9:1849.","journal-title":"Front Immunol"},{"key":"415_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/S1516-31801999000200008","volume":"117","author":"BM Tavares Murta","year":"1999","unstructured":"Tavares Murta BM, Machado JS, Zaparoli M, Lara VC, Murta EF. The relationship of host immune cells, cytokine and nitric oxide production to tumor cells in ovarian carcinoma. Sao Paulo Med J. 1999;117:87\u201392.","journal-title":"Sao Paulo Med J"},{"key":"415_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1600-0897.1997.tb00192.x","volume":"37","author":"PF Terranova","year":"1997","unstructured":"Terranova PF, Rice VM. Review: cytokine involvement in ovarian processes. Am J Reprod Immunol. 1997;37:50\u201363.","journal-title":"Am J Reprod Immunol"},{"key":"415_CR47","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ijc.2910510412","volume":"51","author":"D Vitolo","year":"1992","unstructured":"Vitolo D, et al. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer. 1992;51:573\u201380.","journal-title":"Int J Cancer"},{"key":"415_CR48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cyto.2012.04.020","volume":"59","author":"Y Wang","year":"2012","unstructured":"Wang Y, et al. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells. Cytokine. 2012;59:228\u201336.","journal-title":"Cytokine"},{"key":"415_CR49","first-page":"3369","volume":"15","author":"B Wang","year":"2018","unstructured":"Wang B, et al. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt\/beta-catenin pathway in epithelial ovarian carcinoma cells. Oncol Lett. 2018a;15:3369\u201375.","journal-title":"Oncol Lett"},{"key":"415_CR50","first-page":"420","volume":"49","author":"SC Wang","year":"2018","unstructured":"Wang SC, et al. IL-8 induces epithelial-to-mesenchymal transition of ovarian carcinoma cells: a preliminary study. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018b;49:420\u20134.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"415_CR51","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3389\/fimmu.2018.00546","volume":"9","author":"J Wu","year":"2018","unstructured":"Wu J, Ding J, Yang J, Guo X, Zheng Y. MicroRNA roles in the nuclear factor kappa B signaling pathway in cancer. Front Immunol. 2018;9:546.","journal-title":"Front Immunol"},{"key":"415_CR52","doi-asserted-by":"publisher","first-page":"13234","DOI":"10.1038\/s41598-017-13364-6","volume":"7","author":"Y Xi","year":"2017","unstructured":"Xi Y, et al. Long non-coding HCG18 promotes intervertebral disc degeneration by sponging miR-146a-5p and regulating TRAF6 expression. Sci Rep. 2017;7:13234.","journal-title":"Sci Rep"},{"key":"415_CR53","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2147\/CMAR.S298649","volume":"13","author":"Y Yang","year":"2021","unstructured":"Yang Y, Gong P, Yao D, Xue D, He X. LncRNA HCG18 promotes clear cell renal cell carcinoma progression by targeting miR-152-3p to upregulate RAB14. Cancer Manag Res. 2021;13:2287\u201394.","journal-title":"Cancer Manag Res"},{"key":"415_CR54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbrc.2018.11.151","volume":"508","author":"W Yuan","year":"2019","unstructured":"Yuan W, et al. Comprehensive analysis of lncRNA-associated ceRNA network in colorectal cancer. Biochem Biophys Res Commun. 2019;508:374\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"415_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11684-018-0656-6","volume":"12","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Weinberg RA. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med. 2018;12:361\u201373.","journal-title":"Front Med"},{"key":"415_CR56","first-page":"390","volume":"54","author":"JL Zheng","year":"2018","unstructured":"Zheng JL, Sun J, Zhang H, Zhang Y. Role of microRNA and lncRNA in lens development and cataract formation. Zhonghua Yan Ke Za Zhi. 2018;54:390\u20135.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"415_CR57","first-page":"447","volume":"27","author":"X Zhou","year":"2012","unstructured":"Zhou X, et al. Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Oncol Rep. 2012;27:447\u201354.","journal-title":"Oncol Rep"},{"key":"415_CR58","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.bbrc.2018.04.164","volume":"500","author":"L Zhu","year":"2018","unstructured":"Zhu L, Zhang S, Huan X, Mei Y, Yang H. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts. Biochem Biophys Res Commun. 2018;500:810\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"415_CR59","doi-asserted-by":"publisher","first-page":"9250","DOI":"10.1002\/jcb.28201","volume":"120","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, et al. Construction and analysis of dysregulated lncRNA-associated ceRNA network in colorectal cancer. J Cell Biochem. 2018;120(6):9250\u201363.","journal-title":"J Cell Biochem"},{"key":"415_CR60","doi-asserted-by":"publisher","first-page":"153395","DOI":"10.1016\/j.prp.2021.153395","volume":"221","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, et al. LncRNA-HCG18 regulates the viability, apoptosis, migration, invasion and epithelial-mesenchymal transition of papillary thyroid cancer cells via regulating the miR-106a-5p\/PPP2R2A axis. Pathol Res Pract. 2021;221:153395.","journal-title":"Pathol Res Pract"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00415-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-021-00415-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00415-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T14:05:55Z","timestamp":1676124355000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-021-00415-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1186\/s10020-021-00415-y","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"16 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by The Ethics Committee of Xiangya Hospital, Central South University and all specimens were handled and anonymized according to ethical and legal standards. Written informed consents were obtained from all patients. All the animal experiments were approved by the animal ethics committee of Xiangya Hospital, Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent obtained from study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}